Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,361 | -33,961 | -16,767 | -58,125 | -43,948 |
| Depreciation Amortization | -859 | -320 | -92 | -87 | 14 |
| Accounts receivable | -70 | 7 | 39 | -36 | -10 |
| Other Working Capital | 50,578 | 52,901 | -3,434 | -3,047 | -4,086 |
| Other Operating Activity | 5,772 | 3,925 | 1,786 | 6,468 | 4,616 |
| Operating Cash Flow | $2,060 | $22,552 | $-18,468 | $-54,827 | $-43,414 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,939 | -30,421 | 20,696 | -36,483 | -44,609 |
| PPE Investments | -49 | -21 | -2 | -17 | -17 |
| Investing Cash Flow | $-24,988 | $-30,442 | $20,694 | $-36,500 | $-44,626 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 110,269 | 16,304 | 263 | 87,923 | 87,740 |
| Financing Cash Flow | $110,269 | $16,304 | $263 | $87,923 | $87,740 |
| Beginning Cash Position | 10,157 | 10,157 | 10,157 | 13,561 | 13,561 |
| End Cash Position | 97,498 | 18,571 | 12,646 | 10,157 | 13,261 |
| Net Cash Flow | $87,341 | $8,414 | $2,489 | $-3,404 | $-300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,060 | 22,552 | -18,468 | -54,827 | -43,414 |
| Capital Expenditure | -49 | -21 | -2 | -58 | -58 |
| Free Cash Flow | 2,011 | 22,531 | -18,470 | -54,885 | -43,472 |